Examining the True Prevalence of Hypercortisolism and Its Impact on Managing Resistant Diabetes - Episode 1
Overview of the CATALYST Study for Hypercortisolism
Published on:
Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE, Ralph DeFronzo, MD , Athena Philis-Tsimikas, MD, John Anderson, MD The CATALYST study is discussed by a panel of experts led by Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES.
Video content above is prompted by the following:
- What is the significance of the CATALYST trial? Can you explain the rationale for the study?